Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Sepsis Diagnostics Companies

Sepsis diagnostics companies specialize in developing advanced medical technologies to swiftly and accurately identify sepsis, a life-threatening condition resulting from the body's extreme response to infection. These innovative firms employ cutting-edge methods, such as molecular diagnostics, biomarker analysis, and artificial intelligence algorithms, to detect sepsis markers in blood samples.

Sepsis Diagnostics Key Companies

Latest Sepsis Diagnostics Companies Update

December 2023: Legend Biotech receives China National Medical Products Administration (NMPA) approval for LCAR-017 for relapsed/refractory B-cell lymphomas. This signifies the first regulatory approval for CAR T-cell therapy in China.November 2023: BioMarker has raised $30 million in a Series B funding round, demonstrating investor confidence in the company's AI-powered platform for analyzing brain scans and improving diagnosis of neurological disorders. Jan 2024: BlueRock Therapeutics releases encouraging Phase I/II data for autologous T-cell therapy for PD-L1 negative non-small cell lung cancer. this marks progress in tackling challenging cancer types with autologous therapies.October 2023: CTI BioTech's blood test for early sepsis detection, SepsiSTAT, wins FDA Breakthrough Device Designation. This could expedite the approval process and bring the test to market faster.Jan 2024: Magenta Therapeutics secures $165 million in Series D funding, aiming to advance product development and manufacturing capabilities.August 2023: Novartis expands CAR-T program partnership with Cellares, demonstrating continued commitment to CAR T-cell therapy development.

List of Sepsis Diagnostics Key Companies in the Market

Sandstone Diagnostics Inc. (US)

T2 Biosystems

Immunexpress (US)

Axis-Shield Diagnostics Ltd. (Scotland)

Becton Dickinson and Company (US)

EKF Diagnostics (UK)

Cube Dx GmbH (Austria)

Wolters Kulwer N.V. (Netherlands)

Amara Health (US)

Sepsis Diagnostics Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.